RNA interference against viruses: strike and counterstrike

被引:217
作者
Haasnoot, Joost [1 ]
Westerhout, Ellen M. [1 ]
Berkhout, Ben [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1038/nbt1369
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
RNA interference (RNAi) is a conserved sequence-specific, gene-silencing mechanism that is induced by double-stranded RNA. RNAi holds great promise as a novel nucleic acid-based therapeutic against a wide variety of diseases, including cancer, infectious diseases and genetic disorders. Antiviral RNAi strategies have received much attention and several compounds are currently being tested in clinical trials. Although induced RNAi is able to trigger profound and specific inhibition of virus replication, it is becoming clear that RNAi therapeutics are not as straightforward as we had initially hoped. Difficulties concerning toxicity and delivery to the right cells that earlier hampered the development of antisense-based therapeutics may also apply to RNAi. In addition, there are indications that viruses have evolved ways to escape from RNAi. Proper consideration of all of these issues will be necessary in the design of RNAi-based therapeutics for successful clinical intervention of human pathogenic viruses.
引用
收藏
页码:1435 / 1443
页数:9
相关论文
共 139 条
[1]   Escape from the interferon response associated with RNA interference using vectors that encode long modified hairpin-RNA [J].
Akashi, H ;
Miyagishi, M ;
Yokota, T ;
Watanabe, T ;
Hino, T ;
Nishina, K ;
Kohara, M ;
Taira, K .
MOLECULAR BIOSYSTEMS, 2005, 1 (5-6) :382-390
[2]   Crystal structure of the rabies virus nucleoprotein-RNA complex [J].
Albertini, Aurelie A. V. ;
Wernimont, Amy K. ;
Muziol, Tadeusz ;
Ravelli, Raimond B. G. ;
Clapier, Cedric R. ;
Schoehn, Guy ;
Weissenhorn, Winfried ;
Ruigrok, Rob W. H. .
SCIENCE, 2006, 313 (5785) :360-363
[3]   Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: Myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients [J].
Amado, RG ;
Mitsuyasu, RT ;
Rosenblatt, JD ;
Ngok, FK ;
Bakker, A ;
Cole, S ;
Chorn, N ;
Lin, LS ;
Bristol, G ;
Boyd, MP ;
Macpherson, JL ;
Fanning, GC ;
Todd, AV ;
Ely, JA ;
Zack, JA ;
Symonds, GP .
HUMAN GENE THERAPY, 2004, 15 (03) :251-262
[4]   Safety and efficacy of a lentiviral vector containing three anti-HIV genes - CCR5 ribozyme, tat-rev siRNA, and TAR decoy - in SCID-hu mouse-derived T cells [J].
Anderson, Joseph ;
Li, Ming-Jie ;
Palmer, Brent ;
Remling, Leila ;
Li, Shirley ;
Yam, Priscilla ;
Yee, Jiing-Kuan ;
Rossi, John ;
Zaia, John ;
Akkina, Ramesh .
MOLECULAR THERAPY, 2007, 15 (06) :1182-1188
[5]   Suppression of RNA interference by adenovirus virus-associated RNA [J].
Andersson, MG ;
Haasnoot, PCJ ;
Xu, N ;
Berenjian, S ;
Berkhout, B ;
Akusjärvi, G .
JOURNAL OF VIROLOGY, 2005, 79 (15) :9556-9565
[6]   DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells [J].
Arrighi, JF ;
Pion, M ;
Garcia, E ;
Escola, JM ;
van Kooyk, Y ;
Geijtenbeek, TB ;
Piguet, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (10) :1279-1288
[7]   Lentiviral vector transduction of a dominant-negative rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication [J].
Bahner, Ingrid ;
Sumiyoshi, Teiko ;
Kagoda, Mercy ;
Swartout, Robin ;
Peterson, Denise ;
Pepper, Karen ;
Dorey, Fred ;
Reiser, Jacob ;
Kohn, Donald B. .
MOLECULAR THERAPY, 2007, 15 (01) :76-85
[8]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[9]  
Belfort R, 2002, AM J OPHTHALMOL, V133, P467
[10]   Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing [J].
Bennasser, Y ;
Le, SY ;
Benkirane, M ;
Jeang, KT .
IMMUNITY, 2005, 22 (05) :607-619